NEW YORK (Reuters) - A federal judge on Tuesday rejected Pfizer's bid to recoup about $75.2 million left over from a U.S.
I have selected Pfizer and Verizon as my top two high dividend yield companies to invest in for November 2024. Click here to ...
The Dow Jones Industrial Average slipped for its fourth trading day in a row, as the blue-chip index missed out on a rally ...
Other drug manufacturers declined in the days following the nomination. Pfizer and Moderna have declined 6.9% and 6.2% ...
Jefferies analyst Akash Tewari maintained a Buy rating on Apellis Pharmaceuticals (APLS – Research Report) today and set a price target of ...
Investing in stocks based on valuation metrics is considered a smart strategy. The price-to-earnings (P/E) ratio is often the go-to metric due to its simplicity and ease of use. However, the ...
Biotech-stock investing has one tough test for success - and it's about to get easier ...